Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
3.340
0.00 (0.00%)
At close: Jun 5, 2025
NGX:NEIMETH Revenue
Neimeth International Pharmaceuticals had revenue of 1.21B NGN in the quarter ending March 31, 2025, with 86.08% growth. This brings the company's revenue in the last twelve months to 5.04B, up 111.09% year-over-year. In the year 2024, Neimeth International Pharmaceuticals had annual revenue of 4.49B with 102.98% growth.
Revenue (ttm)
5.04B
Revenue Growth
+111.09%
P/S Ratio
2.80
Revenue / Employee
25.73M
Employees
196
Market Cap
14.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.49B | 2.28B | 102.98% |
Dec 31, 2023 | 2.21B | -709.73M | -24.31% |
Dec 31, 2022 | 2.92B | 216.47M | 8.01% |
Sep 30, 2022 | 2.70B | -343.81M | -11.28% |
Sep 30, 2021 | 3.05B | 207.54M | 7.31% |
Sep 30, 2020 | Pro | Pro | Pro |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BUA Foods | 1,613.06B |
Dangote Cement | 3,757.86B |
MTN Nigeria Communications | 3,665.82B |
Geregu Power | 118.46B |
BUA Cement | 1,006.16B |
Transcorp Power | 343.52B |
Aradel Holdings | 679.85B |
Zenith Bank | 2,315.03B |